AllNewsPhotosVideos
Bharat Biotech International

Bharat Biotech

Bharat biotech, Latest News

Mitigate Covid risk fully with vax for children, say doctors - Hindi News | Mitigate Covid risk fully with vax for children, say doctors | Latest national News at Lokmattimes.com

National :Mitigate Covid risk fully with vax for children, say doctors

Hyderabad, Dec 30 With the government set to rollout vaccination for children in the 15-18 age group from ... ...

Biological E gets approval to conduct trials of Corbevax as booster dose - Hindi News | Biological E gets approval to conduct trials of Corbevax as booster dose | Latest national News at Lokmattimes.com

National :Biological E gets approval to conduct trials of Corbevax as booster dose

The Drug Controller General of India (DCGI) has given approval to the Hyderbad-based pharmaceutical company Biological E to conduct phase 3 clinical trials of its COVID-19 vaccine Corbevax as a booster dose, said sources. ...

Bharat Biotech targets one billion doses of intranasal vaccine annually - Hindi News | Bharat Biotech targets one billion doses of intranasal vaccine annually | Latest national News at Lokmattimes.com

National :Bharat Biotech targets one billion doses of intranasal vaccine annually

Hyderabad, Dec 28 Bharat Biotech is targeting to make one billion doses of its Covid-19 intranasal vaccine annually ... ...

COVID-19 vaccine: 15-18 age group to get Covaxin from Jan 3 - Hindi News | COVID-19 vaccine: 15-18 age group to get Covaxin from Jan 3 | Latest national News at Lokmattimes.com

National :COVID-19 vaccine: 15-18 age group to get Covaxin from Jan 3

Children aged between 15 to 18 who are eligible for vaccination from January 3 next year will only be administered doses of the Covaxin COVID-19 vaccine, sources in the Union Health Ministry said on Tuesday. ...

Covaxin has shown good immune response in children during trials, says Dr NK Arora - Hindi News | Covaxin has shown good immune response in children during trials, says Dr NK Arora | Latest national News at Lokmattimes.com

National :Covaxin has shown good immune response in children during trials, says Dr NK Arora

Covaxin has shown that it has a very good immune response in children in trials, Dr NK Arora, Chairman of Covid Task Force working group, NTAGI, said on Sunday. ...

Covaxin has shown good immune response in children during trials, says Dr NK Arora - Hindi News | Covaxin has shown good immune response in children during trials, says Dr NK Arora | Latest national News at Lokmattimes.com

National :Covaxin has shown good immune response in children during trials, says Dr NK Arora

Covaxin has shown that it has a very good immune response in children in trials, Dr NK Arora, Chairman of Covid Task Force working group, NTAGI, said on Sunday. ...

Covaxin has shown good immune response in children during trials, says Dr NK Arora - Hindi News | Covaxin has shown good immune response in children during trials, says Dr NK Arora | Latest national News at Lokmattimes.com

National :Covaxin has shown good immune response in children during trials, says Dr NK Arora

Covaxin has shown that it has a very good immune response in children in trials, Dr NK Arora said on Sunday. ...

Proven record for safety, says Bharat Biotech after Covaxin gets emergency usage nod for kids above 12 yrs - Hindi News | Proven record for safety, says Bharat Biotech after Covaxin gets emergency usage nod for kids above 12 yrs | Latest national News at Lokmattimes.com

National :Proven record for safety, says Bharat Biotech after Covaxin gets emergency usage nod for kids above 12 yrs

Covaxin has a proven record for safety and efficacy from all the variants of COVID-19, said Bharat Biotech after its vaccine received emergency usage approval from the Drugs Controller General of India (DCGI) for kids aged between 12-18 years. ...